Ropes & Gray Names 26 New Partners

Global law firm Ropes & Gray is pleased to announce that 26 attorneys have been named partners of the firm, effective January 1, 2027.

“This is an extraordinary class. They know our clients’ industries deeply, and they’re using AI to bring sharper insight to clients, said Julie Jones, Chair of Ropes & Gray. “They’re curious, agile, and collaborative, which is Ropes & Gray at its best. They’re the next generation of leaders our clients will count on for decades to come.”

Ropes & Gray’s new partners are trusted advisors to clients navigating critical challenges and opportunities across alternative assets, asset management, data privacy and cybersecurity, employment and benefits, health care, life sciences compliance, litigation and enforcement, private capital, real estate, strategic transactions, and tax. They empower leading companies, investment funds, and institutions worldwide to manage risk and capitalize on opportunities.

Here are the newest members of Ropes & Gray’s partnership:

Michael Allen (Boston, Real Estate) represents private funds, mortgage REITs, developers, hedge funds, family offices, and other institutional investors across real estate asset classes. He advises clients on commercial real estate debt and equity transactions, including repurchase facilities, note-on-note financings, and other back leverage arrangements, joint ventures, and co-investments.

Sarah Blumenthal (New York, Health Care) provides strategic, transactional, and regulatory counsel to hospitals, health systems, universities, medical schools, and human services providers. She advises clients across complex strategic transactions, including mergers, acquisitions, affiliations, and joint ventures.

Madeline (Mady) Cooper (Boston, Executive Compensation & Employee Benefits) advises clients on executive compensation, employment, and benefits matters in private equity and strategic transactions, including incentive equity, deferred compensation, and severance arrangements. Leveraging her prior experience as a benefits consultant, Mady provides practical solutions to benefit transition and integration issues in carve-out transactions.

Andrea Daley (Boston, Private Capital Transactions) advises leading private equity sponsors and their portfolio companies in a broad range of transactions, including leveraged buyouts, carve-outs, and minority and growth investments. Her experience spans a range of industries across the technology, consumer, business services, and infrastructure spaces.

David Dowling (London, Mergers & Acquisitions) represents corporate venture corporations and their venture funds, financial investors, and start-ups in mergers and acquisitions and venture capital transactions. He focuses on IP-rich and regulation-heavy industries including life sciences, medtech, pharmaceuticals, biotech, healthcare, artificial intelligence, defense, and insurance.

Kelly Finn (Boston, Mergers & Acquisitions) represents public and private companies and their boards, investment banks, and private equity firms in mergers and acquisitions, capital markets transactions, financings, and other strategic transactions. She also advises clients on issues of corporate governance and securities law.

Michelle Huynh (Boston, Asset Management) advises asset management clients on a wide range of matters concerning listed closed-end funds, interval and tender offer funds, mutual funds, ETFs, and other investment programs including innovative structures that provide investors access to alternative assets.

Joshua Jackson (Boston, Technology & Intellectual Property) advises public and private companies, investors, and universities on transactions driven by data, technology, and intellectual property, including licensing, research collaborations, joint ventures and M&A. His work spans the fintech, artificial intelligence, digital health, biotechnology, and software verticals.

Christopher Labosky (Boston, Asset Management) advises asset managers, public fund sponsors, private equity firms, and institutional investors on complex transactional and regulatory matters. He advises fund sponsors on the launch of innovative publicly offered products, including ETFs, interval and tender offer funds, alternative retail funds, and tokenized investment vehicles.

Jessica Lees (Los Angeles, Asset Management) represents investment management clients in the establishment, registration, reorganization, termination, and ongoing operation of retail and institutional fund products, as well as on compliance program design and implementation. She also advises clients on disclosure and fund operations matters, including offering documents and shareholder communications.

Edward Machin (London, Data, Privacy & Cybersecurity) advises on legal and regulatory issues in the areas of privacy, data protection and cyber security, artificial intelligence, and digital regulation. He also helps clients respond to law enforcement and data protection authority requests, and advises on personal data breaches and contentious rights requests.

Elizabeth Madsen (Chicago, Asset Management) represents registered funds, their independent directors, and investment advisors in a wide array of regulatory, transactional, governance, and compliance matters. Her practice spans the full registered product spectrum, including ETFs, listed closed-end funds, interval and tender offer funds, and alternative investment strategies.

Alison McLaughlin (Boston, Litigation & Enforcement) advises private equity sponsors, funds, and companies on liability and transactional risk insurance, negotiating representations and warranties policies and maximizing coverage across insurance products. She also provides guidance on coverage disputes, insurance-related investments, and risk management.

Marc Migliazzo (Boston, Asset Management) represents financial sponsors and institutional investors on fund transactions and private equity investments, with a focus on GP-led secondaries and fund liquidity solutions of all types, including continuation funds, LP tenders, and structured preferred solutions.

Dima Orendarets (London, Real Estate) leads the firm's real estate finance practice in London, advising sponsors, debt funds, and institutional investors on investment, development, senior, mezzanine, and back-leverage financings. He advises originators on structured finance transactions, private securitizations, and warehouse financings. His work spans logistics, hospitality, build-to-rent, student accommodation, and offices.

Rupert Phillips (London, Litigation & Enforcement) advises clients on EU and UK competition law including international merger control, FDI and FSR processes for complex cross-border transactions, and conduct investigations before agencies in Europe and Asia. He advises clients in various sectors including private equity, technology, life sciences, and semiconductors.

Nicholas Roper (Boston, Mergers & Acquisitions) represents public companies, investment banks and private equity firms, and their portfolio companies, in connection with capital markets transactions, mergers and acquisitions, and other strategic transactions. He also advises clients on a range of securities law and corporate governance issues.

Eli Rosenbaum (Boston, Asset Management) co-leads Ropes & Gray's institutional investor practice, serving as a trusted advisor to many of the largest institutional limited partners in private funds. Clients engage Eli on their highest-priority matters, from anchor and seed investments and portfolio secondaries to "top of the house" initiatives on governance and structuring.

Peter (Pete) Scherer (Boston, Real Estate) represents private equity clients, endowments, sovereign wealth funds, hedge funds, and other financial institutions in a wide variety of commercial real estate investments including acquisitions and dispositions, financings, and formation of joint ventures for real estate investments.

Rob Schmidt (Boston, Alternative Asset Opportunities) represents institutional investors, sovereign wealth funds, and other asset managers in a broad range of private market transactions, with a focus on GP-led recapitalizations, LP secondaries trades, preferred equity fund financings, portfolio dispositions and acquisitions, and other private funds liquidity solutions.

Michael Shulman (New York, Tax) advises private equity firms and other clients on the U.S. tax aspects of a broad array of matters, focusing on M&A transactions and business restructurings, including for creditors and distressed companies. He also represents sponsors forming and operating private funds with diverse investment strategies and tax structures.

Kim Ton-That (New York, Private Capital Transactions) advises private equity sponsors and their portfolio companies on complex transactions, including mergers and acquisitions, leveraged buyouts, joint ventures, carve-outs, add-ons, dispositions, and corporate restructurings. Kim works with clients across several industries, including technology, industrials, business services, and health care.

Kevin White (San Francisco, Asset Management) represents private investment fund sponsors on all aspects of continuation vehicle transactions and similar fund restructurings, as well as fund formation, economic and governance considerations, and co-investment arrangements.

Rebecca Williams (Washington, D.C., Life Sciences Regulatory & Compliance) provides legal and strategic advice to pharmaceutical, biotechnology, medical device, food, and cosmetic companies on a broad range of issues under the Food, Drug, and Cosmetic Act and the Public Health Service Act.

Young Yoon (New York, Asset Management) represents private fund sponsors on fund formation across private equity, credit, special situations, hedge fund, and real estate strategies, as well as regulatory compliance, governance, and other ongoing matters. He also advises institutional investors on their investments in private funds and co-investment vehicles. In addition, he regularly advises with respect to fund-related transactions.

Billy Zhang (Hong Kong, Alternative Asset Opportunities) represents global investors on a variety of investment vehicles and transactions, including sovereign wealth funds, pension plans, continuation vehicles, and joint venture arrangements. His practice focuses on real estate, private equity, infrastructure, venture capital, and technology.